← Leaderboards
Erin Frazee Barreto
Mayo Clinic Rochester
$1,086,246
Attributed
$1,086,246
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $247.6K · FY2020–24$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$986,246 · 1
AHRQ$100,000 · 1
By mechanism
K23$986,246 · 1
R03$100,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Steven Offer$1,698,027
- Andrew D Rule$13,956,498
- Jennifer Seno McDonald$486,745
- Nathan K Lebrasseur$21,937,905
- Christopher M Gillen$349,809
Others in their field
Other Emerging Leaders on “Critical Illness”
- Oliver Brand · Emory University$18,504,645
- Vanessa Rivera-Amill · Ponce School Of Medicine$13,362,042
- Rajni Samavedam · Booz Allen Hamilton$9,935,296
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
- Mayur B Patel · Vanderbilt University Medical Center$9,075,045
- Hemali Phatnani · New York University School Of Medicine$8,533,907
Research focus
Critical IllnessAdoptedCreatinineAchievementAntibiotic ResistanceAntibioticsAntibiotic TherapyAdultBacterial ResistanceAcute Renal Failure With Renal Papillary NecrosisBeta-LactamsBioinformaticsBiological MarkersBlood SpecimenCensusesCessation Of LifeCharacteristicsBacterial Antibiotic ResistanceClinicClinical PracticeClinical TranslationCohortCoupledDesign
Grant awards (7)
Beta-lactam individualization for critically ill patients$197,640
K23 · FY2024 · AI · contact PI
Beta-lactam individualization for critically ill patients$197,640
K23 · FY2023 · AI · contact PI
Beta-lactam individualization for critically ill patients$197,640
K23 · FY2022 · AI · contact PI
Enhanced kidney follow-up for AKI survivors in Care Transitions (the ACT Study)$49,999
R03 · FY2022 · HS · contact PI
Beta-lactam individualization for critically ill patients$196,663
K23 · FY2021 · AI · contact PI
Enhanced kidney follow-up for AKI survivors in Care Transitions (the ACT Study)$50,001
R03 · FY2021 · HS · contact PI
Beta-lactam individualization for critically ill patients$196,663
K23 · FY2020 · AI · contact PI